Search results
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 20 hours agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 6 hours agoModerna stock is yo-yoing after the company unveiled early-stage test results for its...
Merck to Report Earnings One Month After Major Drug Approval. What Investors Are Watching.
Barrons.com· 4 hours agoThe Winrevair approval should help cushion the blow of the expiration of the patents protecting...
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in...
FOX 59 Indianapolis· 23 hours agoUpon the execution of the agreement, Hanmi Pharmaceutical will conduct a phase 1 clinical trial to...
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 13 hours agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express PD-L1 (TACTI-003, Cohort B) shows ...
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
Benzinga via Yahoo Finance· 8 hours agoThe investigational immuno-oncology combination demonstrates an overall response rate (ORR) of...
Merck Earnings Preview: Strong quarter expectations on the back of core products' growth
Seeking Alpha· 10 hours agoMerck (NYSE:MRK) is scheduled to announce Q1 earnings results on Thursday, April 25th, before market...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 2 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 10 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
...Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in...
Morningstar· 2 days agoThe VERSATILE-002 trial is evaluating Versamune® HPV (formerly PDS0101) in combination with the immune checkpoint...